Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.
Snydman
D R
DR
Department of Medicine, New England Medical Center, Boston, MA 02111.
Werner
B G
BG
Tilney
N L
NL
Kirkman
R L
RL
Milford
E L
EL
Cho
S I
SI
Bush
H L
HL
Levey
A S
AS
Strom
T B
TB
Carpenter
C B
CB
D000328:Adult; D000914:Antibodies, Viral / Q000008:administration & dosage / Q000032:analysis / Q000592:standards; D002102:Cadaver; D002648:Child; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006084:Graft Rejection; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation; D014019:Tissue Donors
D000914:Antibodies, Viral